Drug Type Small molecule drug |
Synonyms PF-06260933 |
Target |
Mechanism MAP4K4 inhibitors(mitogen-activated protein kinase kinase kinase kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H13ClN4 |
InChIKeyKHPCIHZXOGHCLY-UHFFFAOYSA-N |
CAS Registry1811510-56-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | 06 Oct 2015 |